, Tracking Stock Market Picks
Enter Symbol:
Ace (ACE) [hlAlert]

up 16.43 %

Ace (ACE) rated Overweight with price target $117 by Barclays

Posted on: Friday,  Nov 22, 2013  12:25 PM ET by Barclays

Barclays rated Overweight Ace (NYSE: ACE) on 11/22/2013. Previously Barclays rated Overweight Ace (NYSE: ACE) on 04/02/2013., when the
stock price was $89.01. Since then, Ace has gained 16.44% as of 01/05/2016's recent price of $103.64.
If you would have followed the previous Barclays's recommendation on ACE, you would have gained 16.43% of your investment in 1008 days.

Alcon, Inc. is the world's leading eye care company. Alcon, which has been dedicated to the ophthalmic industry for sixty years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestle, S.A., the world's largest food company. All trademarks noted in this release are the property of Alcon, Inc., with the exception of Ciprodex, which is a registered trademark of Bayer AG and licensed to Alcon, Inc. by Bayer Healthcare AG. Moxifloxacin is licensed to Alcon, Inc. by Bayer Healthcare AG.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/22/2013 12:25 PM Buy
102.62 117.00
as of 12/13/2013
1 Week down  -2.63 %
1 Month up  2.01 %
3 Months up  8.27 %
1 YTD down  -3.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/24/2013 12:25 PM Buy
92.07 112.00
4/2/2013 12:25 PM Buy
89.01 103.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy